Clinical Trial Update: Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety [Phase 2]

View source ↗

Summary

The document notes the completion of a Phase 2 safety and effectiveness trial comparing BCI-540 to placebo for major depressive disorder with concomitant anxiet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• BCI-540

Snippet

Sponsor: BrainCells Inc. | Conditions: Major Depressive Disorder, Anxiety | Phase 2 | Status: COMPLETED